| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Neratinib |
來那替尼 Neratinib HKI-272 |
698387-09-6 |
詳細
|
| Vericiguat |
Vericiguat 維利西呱; BAY1021189 |
1350653-20-1 |
詳細
|
| PARGYLINE HYDROCHLORIDE |
優(yōu)降寧鹽酸鹽 Pargyline hydrochloride |
306-07-0 |
詳細
|
| lenvatinib Mesylate |
樂伐替尼甲磺酸鹽 |
857890-39-2 |
詳細
|
| Erlotinib hydrochloride |
鹽酸埃羅替尼 Erlotinib Hydrochloride (CP-358774 Hydrochloride) |
183319-69-9 |
詳細
|
| PF-07321332 |
帕羅韋德 |
2628280-40-8 |
詳細
|
| Abemaciclib |
阿貝西利 Abemaciclib LY2835219 |
1231929-97-7 |
詳細
|
| Lenvatinib |
樂伐替尼 |
417716-92-8 |
詳細
|
| FMoc-Val-Cit-PAB |
Fmoc-Val-Cit-PAB |
159858-22-7 |
詳細
|
| 7-Chloro-6-fluoro-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione |
7-氯-6-氟-1-(2-異丙基-4-甲基吡啶-3-基)吡啶并[2,3-d]嘧啶-2,4(1H,3H)-二酮 |
2252403-82-8 |
詳細
|
| N-(3-Chlorophenyl)-6,7-dimethoxyquinazolin-4-amine hydrochloride |
N-(3-氯苯基)-6,7-二甲氧基-4-喹唑啉胺鹽酸鹽 |
170449-18-0 |
詳細
|
| (S)-N-(5-(2-(1-cyclopropylethyl)-4-morpholino-3-oxo-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-6-yl)-4-methylthiazol-2-yl)acetamide |
EX-A5492 |
2504036-13-7 |
詳細
|
| 2,3-DIMETHYL-4-NITROANILINE |
2,3-二甲基-4-硝基苯胺 |
80879-86-3 |
詳細
|
| D-(+)-Cellobiose |
D-纖維二糖 |
528-50-7 |
詳細
|
| 1-Phenyl-2-propyn-1-ol |
1-苯基-2-丙炔-1-醇 |
4187-87-5 |
詳細
|
| Lasmiditan |
拉米地坦 |
439239-90-4 |
詳細
|
| tert-butyl N-[(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)cyclohexyl]carbamate |
N-[((1R,2S,5S)-2-氨基-5-(二甲基氨基甲?；?環(huán)己基]氨基甲酸叔丁酯 |
365998-36-3 |
詳細
|
| (6R)-9-fluorospiro[3,13-dioxa-2,11,16,20,21,24-hexazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaene-15,1'-cyclopropane]-17-one |
SCHEMBL22849676; EX-A6856 |
2375441-71-5 |
詳細
|
| N-(5-Chloropyridin-2-yl)oxalaMic acid ethyl ester |
依度沙班雜質(zhì)C |
349125-08-2 |
詳細
|
| (S)-tert-Butyl (2-(2-cyano-4,4-difluoropyrrolidin-1-yl)-2-oxoethyl)carbamate |
(S)-叔丁基(2-(2-氰基-4,4-二氟吡咯烷-1-基)-2-氧代乙基)氨基甲酸酯 |
1448440-50-3 |
詳細
|
| 3-[(1-Propylbenzimidazol-2-yl)carbamoyl]benzoic acid |
化合物HS220 |
1570374-32-1 |
詳細
|
| 4-(Diethylamino)but-2-yn-1-yl 2-hydroxy-2,2-diphenylacetate (Oxybutynin Impurity) |
4-(二乙氨基)but-2-yn-1-基2-羥基-2,2-二苯乙酸 |
14943-53-4 |
詳細
|
| PUROMYCIN AMINONUCLEOSIDE |
Puromycin aminonucleoside 氨基核苷嘌呤霉素 NSC 3056 |
58-60-6 |
詳細
|
| NXL 104 |
阿維巴坦鈉 NXL 104 Avibactamsodium |
1192491-61-4 |
詳細
|
| 4-(Ethyl(propyl)amino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate |
4-(乙基(丙基)氨基)丁-2-炔-1-基 2-環(huán)己基-2-羥基-2-苯基乙酸酯 |
1215677-72-7 |
詳細
|
| Empagliflozin |
Empagliflozin 恩格列凈 BI 10773 |
864070-44-0 |
詳細
|
| (Z)-7-[(2R)-2-amino-2-carboxyethyl]sulfanyl-2-[[(1S)-2,2-dimethylcyclopropanecarbonyl]amino]hept-2-enoate |
西司他汀雜質(zhì) |
877674-82-3 |
詳細
|
| Z-IETD-FMK |
CASPASE-8抑制劑 |
210344-98-2 |
詳細
|
| AZD9291 |
奧希替尼 Osimtinib (AZD9291) |
1421373-65-0 |
詳細
|
| N-[21-ethyl-20-[2-(1-methoxyethyl)-5-(4-methylpiperazin-1-yl)pyridin-3-yl]-17,17-dimethyl-8,14-dioxo-15-oxa-4-thia-9,21,27,28-tetrazapentacyclo[17.5.2.12,5.19,13.022,26]octacosa-1(25),2,5(28),19,22(26),23-hexaen-7-yl]-2-methylcyclopropane-1-carboxamide |
RAS-IN-2 |
2765081-21-6 |
詳細
|
| 6-Methyl-N-[(E)-1-pyridin-2-ylethylideneamino]-4a,5-dihydro-2H-[1,2,4]triazino[5,6-b]indol-3-amine |
VLX600 |
1622945-04-3 |
詳細
|
| Lapatinib |
Lapatinib 拉帕替尼 |
231277-92-2 |
詳細
|
| ULK-101 |
2-Thiophenecarboxamide, N-[(1S)-1-cyclopropyl-2,2,2-trifluoroethyl]-4-[6-(4-fluorophenyl)pyrazolo[1,5-a]pyrimidin-3-yl]- |
2443816-45-1 |
詳細
|
| Dasatinib |
達沙替尼 |
302962-49-8 |
詳細
|
| 2,2-Dichloro-N-(2,6-dimethylphenyl)acetamide |
2,2-二氯-N-(2,6-二甲基苯基)乙酰胺 |
39084-88-3 |
詳細
|
| Baricitinib |
巴瑞克替尼 |
1187594-09-7 |
詳細
|
| 4-(Carboxymethyl)-2-ethoxybenzoic acid |
PKCiota-IN-49 |
2230055-52-2 |
詳細
|
| Olaparib |
奧拉帕尼 Olaparib (AZD2281; KU0059436) |
763113-22-0 |
詳細
|
| A2A receptor antagonist 3 |
化合物 A2A RECEPTOR ANTAGONIST 3 |
2738606-83-0 |
詳細
|
| 1-[(7R)-7-ethyl-7-hydroxy-5,6-dihydrocyclopenta[b]pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one |
ZN-c3 |
2376146-48-2 |
詳細
|
| Terbinafine hydrochloride |
Terbinafine HCl 鹽酸特比萘芬 TDT 067 hydrochloride |
78628-80-5 |
詳細
|
| PD 0332991 isethionate |
帕布昔利布羥乙基磺酸鹽 |
827022-33-3 |
詳細
|
| Upadacitinib |
Upadacitinib 烏帕替尼 ABT-494 |
1310726-60-3 |
詳細
|
| Rivaroxaban |
Rivaroxaban 利伐沙班 BAY 59-7939 |
366789-02-8 |
詳細
|
| 3H-Imidazo[4,5-b]pyridine, 2-[[4-[4-(2-benzofuranyl)-2-thiazolyl]-1-piperidinyl]methyl]- |
BAY-179 |
2764880-87-5 |
詳細
|
| (S)-4-Ethyl-4-hydroxy-7,8-dihydro-1h-pyrano[3,4-f]indolizine-3,6,10(4H)-trione |
7-乙基-10-羥基喜樹堿中間體 |
110351-94-5 |
詳細
|
| S-(5′-Adenosyl)-L-homocysteine |
S-(5'-腺苷)-L-高半胱氨酸 |
979-92-0 |
詳細
|
| Afatinib |
阿法替尼 |
850140-72-6 |
詳細
|
| Dasatinib monohydrate |
達沙替尼一水合物 Dasatinib (BMS-354825) monohydrate |
863127-77-9 |
詳細
|
| Deudextromethorphan |
六氘代右美沙芬 |
1079043-55-2 |
詳細
|
| Azvudine |
4-氨基-1-(4-C-疊氮基-2-脫氧-2-氟-BETA-D-呋喃阿拉伯糖基)-2(1H)-嘧啶酮 |
1011529-10-4 |
詳細
|
| N-[(1R,2R)-2-hydroxycyclobutyl]-7-(methylamino)-5-[(2-oxo-1-pyridin-2-ylpyridin-3-yl)amino]pyrazolo[1,5-a]pyrimidine-3-carboxamide |
BDBM424517 |
2272905-14-1 |
詳細
|
| 1,3,5-Triazine-2,4(1H,3H)-dione, 6-[(6-chloro-2-methyl-2H-indazol-5-yl)imino]dihydro-3-[(1-methyl-1H-1,2,4-triazol-3-yl)methyl]-1-[(2,4,5-trifluorophenyl)methyl]-, (6E)- |
恩賽特韋 |
2647530-73-0 |
詳細
|
| Tafluprost ethyl amide |
他氟乙酰胺 |
1185851-52-8 |
詳細
|
| JQKD82 |
JQKD-82 |
2410512-38-6 |
詳細
|
| Lactobionic acid |
乳糖酸 |
96-82-2 |
詳細
|
| D(+)-Raffinose pentahydrate |
D(+)-五水棉子糖 |
17629-30-0 |
詳細
|
| (1S,3S)-N1-(5-(Pentan-3-yl)pyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine |
KB-0742 HCL |
2416873-83-9 |
詳細
|
| 2-[2-(2-Fluorophenyl)-2-oxoethyl]propanedinitrile |
2-[2-(2-氟苯基)-2-氧代乙基]丙二腈 |
312307-38-3 |
詳細
|
| Benzamide, 2,4,6-trifluoro-N-[6-[(1-methyl-4-piperidinyl)carbonyl]-2-pyridinyl]-, hydrochloride |
613677-28-4 |
613677-28-4 |
詳細
|
| Maribavir |
Maribavir 馬立巴韋 |
176161-24-3 |
詳細
|
| 4-[[(3,5-Dimethoxy-4-methylbenzoyl)-(3-phenylpropyl)amino]methyl]benzoic acid |
|
679790-27-3 |
詳細
|
| ((2R,3R,4R)-3-((4-Chlorobenzoyl)oxy)-4-fluoro-4-methyl-5-oxotetrahydrofuran-2-yl)methyl 4-chlorobenzoate |
((2R,3R,4R)-3-((4-氯苯甲?；?氧基)-4-氟-4-甲基-5-氧代四氫呋喃-2-基)甲基4-氯苯甲酸酯 |
1294481-79-0 |
詳細
|
| Ethyl (R)-4-((2-(5-(2-fluoro-3-methoxyphenyl)-3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl)-1-phenylethyl)amino)butanoate |
(R)-4-((2-(5-(2-氟-3-甲氧基苯基)-3-(2-氟-6-(三氟甲基)芐基)-4-甲基-2,6-二氧代-3-(E),6-二氫嘧啶-1(2H)-基)-1-苯基乙基)氨基)丁酸酯 |
832720-84-0 |
詳細
|
| FASORACETAM |
法索西坦 Fasoracetam (NS 105) |
110958-19-5 |
詳細
|
| (3-Aminopropyl)trimethoxysilane |
3-氨丙基三甲氧基硅烷 |
13822-56-5 |
詳細
|
| 4-(Trimethylsilyl)-3-butyn-2-one |
4-三甲硅基-3-丁炔-2-酮 |
5930-98-3 |
詳細
|
| Fmoc-L-Proline |
Fmoc-L-脯氨酸 |
71989-31-6 |
詳細
|
| Methanone, (6-bromo-2-pyridinyl)(1-methyl-4-piperidinyl)-, hydrobromide (1:1) |
LASMIDITAN 中間體 |
1338000-32-0 |
詳細
|
| N-Methylcarbonyl-2-chloroacetamidrazone |
2-(2-氯-1-亞氨乙基)肼甲酸甲酯 |
155742-64-6 |
詳細
|
| 4-[({4-[bis(morpholin-4-yl)-1,3,5-triazin-2-yl]phenyl}carbamoyl)amino]benzoic acid |
4-(3-(4-(4,6-二嗎啉-1,3,5-三嗪-2-基)苯基)脲基)苯甲酸 |
1197160-66-9 |
詳細
|
| Alflutinib |
Alflutinib |
1869057-83-9 |
詳細
|
| (2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)-ethoxy)-3-(4-fluorophenyl)morpholine hydrochloride |
(2R3S)-2-[(1R)-1-[35-雙(三氟甲基)苯基]乙氧基]-3-(4-氟苯基)-嗎啉鹽酸鹽阿瑞吡坦中間體 |
171482-05-6 |
詳細
|
| 2-[(Trimethylsilyl)ethynyl]thiophene |
2-三甲基硅乙炔基噻吩 |
40231-03-6 |
詳細
|
| (S)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine N-acetyl-L-leucine salt |
(S)-1-(3-乙氧基-4-甲氧基苯基)-2-(甲基磺?；?乙胺 N-乙?；?L-亮氨酸鹽 |
608141-43-1 |
詳細
|
| 2-chloro-5-(2-fluorophenyl)-1H-pyrrole-3-carbonitrile (Vonoprazan Impurity） |
2-氯-5-(2-氟苯基)-1H-吡咯-3-甲腈 |
1240948-72-4 |
詳細
|
| 2-PHTHALIMIDOETHANESULFONYL CHLORIDE |
2-苯二(甲)酰亞胺基乙烷磺酰氯 |
4403-36-5 |
詳細
|
| Solifenacin |
索非那新 Solifenacin |
242478-37-1 |
詳細
|
| 2,4,6-TRIFLUOROBENZOYL CHLORIDE |
2,4,6-三氟苯甲酰氯 |
79538-29-7 |
詳細
|
| N-((2R,3S)-1-(1-(4-fluorophenyl)-1H-indazol-5-yl)-4,4-dimethyl-5-oxo-2- phenylpyrrolidin-3-yl)cyclopropanecarboxamide |
GLUCOCORTICOID RECEPTOR MODULATOR-1 |
2452396-89-1 |
詳細
|
| Dapagliflozin |
Dapagliflozin 達格列凈 BMS-512148 |
461432-26-8 |
詳細
|
| Bemnifosbuvir hemisulfate |
AT-527 |
2241337-84-6 |
詳細
|
| 6-hydroxy-8-(1-hydroxy-2-((2-(4-methoxyphenyl)-1,1-dimethylethyl)amino)ethyl)-2H-1,4-benzoxazin-3(4H)-one |
奧達特羅 Olodaterol |
868049-49-4 |
詳細
|
| Dapagliflozin ((2S)-1,2-propanediol, hydrate) |
達格列凈一水丙二醇 |
960404-48-2 |
詳細
|
| Apalutamide |
阿帕魯胺 Apalutamide (ARN-509) |
956104-40-8 |
詳細
|
| Fulvestrant (Faslodex) |
Fulvestrant 氟維司群 ICI 182780 ZD 9238 ZM 182780 |
129453-61-8 |
詳細
|
| Enzalutamide |
Enzalutamide 恩雜魯胺 MDV3100 |
915087-33-1 |
詳細
|
| Racecadotril |
消旋卡多曲 |
81110-73-8 |
詳細
|
| GW 4064 |
3-(2,6-二氯苯基)-4-(3'-羧基-2-氯二苯乙烯-4-基)氧甲基-5-異丙基異惡唑 |
278779-30-9 |
詳細
|
| 5,7-DI-CHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE HCL |
5,7-二氯-1,2,3,4-四氫異喹啉鹽酸鹽 |
73075-47-5 |
詳細
|
| Hederagenin |
常春藤皂甙元 |
465-99-6 |
詳細
|
| (2R,3R,4R,5R)-2-[(4-Chlorobenzoyloxy)methyl]-4-fluoro-5-hydroxy-4-methyloxolan-3-yl 4-chlorobenzoate |
(2R,3R,4R,5R)-2-[(4-氯苯甲酰)甲基]-4-氟-5-羥基-4-甲基氧雜環(huán)戊烷-3-基4-氯苯甲酸 |
1294481-80-3 |
詳細
|
| Eliapixant |
依利哌嗪 |
1948229-21-7 |
詳細
|
| 2-(3-fluoro-2-propan-2-ylphenyl)-9-[[4-[1-methyl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]-7H-purin-8-one |
化合物 USP1-IN-2 |
2098212-05-4 |
詳細
|
| 1-cyclopropyl-2-[(1S,4S)-5-[2-fluoro-5-[(4-oxo-3H-phthalazin-1-yl)methyl]benzoyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]ethane-1,2-dione |
GLXC-25722 SC10912 |
1379676-56-8 |
詳細
|
| MAGL-IN-6 |
化合物 MAGL-IN-6 |
2414320-29-7 |
詳細
|
| 1(4H)-Pyrimidineacetamide, N-(2-(diethylamino)ethyl)-2-(((4-fluorophenyl)methyl)thio)-5-((1-methyl-1H-pyrazol-4-yl)methyl)-4-oxo-N-((4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methyl)- |
SB-435495 |
304694-39-1 |
詳細
|
| (2R,3R,4R,5R)-5-(2,6-diamino-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)-4-methyltetrahydrofuran-3-ol |
ADENOSINE |
1412427-25-8 |
詳細
|
| 3-Isoxazolecarboxamide, N-(2-cyclohexyl-2,3-dihydro-1,5-dimethyl-3-oxo-1H-pyrazol-4-yl)-4-methyl-5-[(2R,3S)-3,5,5-trimethyl-1,4-dioxan-2-yl]- |
LTP001 |
1825371-51-4 |
詳細
|
| 5-[[2-(4-fluoro-3-methoxy-5-methylanilino)-5-methylpyrimidin-4-yl]amino]-2-oxo-1,3-benzoxazol-3-yl]methyl dihydrogen phosphate |
2(3H)-Benzoxazolone, 5-[[2-[(4-fluoro-3-methoxy-5-methylphenyl)amino]-5-methyl-4-pyrimidinyl]amino]-3-[(phosphonooxy)methyl]- |
1237168-58-9 |
詳細
|